Clinical trial
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With…
NCT00006164 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00006164 |
|---|---|
| Title | Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment |
| Official title | Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C) |
| Acronym | HALT-C |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH National Institute on Minority Health and Health Disparities (NIMHD) National Cancer Institute (NCI) Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis c, Cirrhosis, Liver, Fibrosis, Hepatic Cirrhosis |
| Intervention type | Drug |
| Interventions | Peginterferon alfa-2a + Ribavirin, Peginterferon alfa-2a |
| Enrollment | 1,050 |
| Start date | Jun 1, 2000 |
| Primary completion | Apr 1, 2007 |
| Completion | Oct 1, 2009 |
| First posted | Aug 9, 2000 |
| Last update posted | May 12, 2020 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: